Addiction - Articles - Page 9 | CARLAT PUBLISHING

Sleep Apnea in Patients With Substance Use Disorders: A Primer

August 23, 2018

Rehan Aziz, MD Associate Professor of Psychiatry and Neurology, Rutgers University—Robert Wood Johnson Medical School Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There are three types of sleep apnea: obstructive sleep apnea (OSA), central sleep apnea, and mixed. Of these, OSA is by far the most common, and that’s what we’ll focus on in this article. OSA is caused by excessive relaxation of the throat during sleep, which in some people causes enough obstruction to impede the flow of air.

Treating Insomnia With Addiction

August 23, 2018

Eric Hermes, MD

Eric Hermes, MD Assistant Professor, Department of Psychiatry, Yale School of Medicine, New Haven, CT Dr. Hermes has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

With substance use disorders (SUDs) that are comorbid with chronic insomnia, what would you say are some of the main treatment challenges?

Non-Addictive, Pharmacological Options for Sleep

August 23, 2018

Daniel Carlat, MD

Daniel Carlat, MD Publisher, The Carlat Addiction Treatment Report Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this month’s interview with Dr. Eric Hermes, we learned about his approach to treating insomnia in patients with substance use disorders, with a focus on cognitive behavioral therapy. In this article, we’ll look at some non-addictive pharmacological options.

Adolescents With ADHD and Substance Use Disorders: A Primer

July 1, 2018

Candace Good, MD

Candace Good, MD Child and adolescent psychiatrist, SunPointe Health, State College, PA Dr. Good has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

You are evaluating a 16-year-old boy referred for mandated substance use treatment by his high school, where he was found drinking alcohol and smoking cannabis with a friend in the restroom.

Talking to Parents and Adolescent Patients About Substance Use

July 1, 2018

Joanna Quigley, MD

Joanna Quigley, MD Associate medical director for Child and Adolescent Ambulatory Services, University of Michigan, Ann Arbor, MI Dr. Quigley has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Since they already often seem two steps ahead of us, with adolescents it can be really helpful to use direct routes. Be very specific in your questions. For example, don’t just ask, “Do you smoke?” Ask, “Are you using any nicotine products? What are you using in your vape?”

The Neuroscience Behind Addictions and SSRIs

June 1, 2018

Edmund S. Higgins, MD.

Edmund M. Higgins, MD Clinical associate professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina. Co-author of The Neuroscience of Clinical Psychiatry: The Pathophysiology of Behavior and Mental Illness, 3rd ed. (Wolters Kluwer). Dr. Higgins has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If we think of the molecules (the endorphins or the opioids) as “keys” and the receptors on the neurons as “locks,” then one needs the right key in the lock to get the reward—to turn on the good feelings.

Treating Chronic Pain When There’s Addiction: A Primer

May 1, 2018

Michael McGee, MD

Michael McGee, MD Chief medical officer, The Haven at Pismo, Avila Beach, CA. Author of The Joy of Recovery: A Comprehensive Guide to Healing from Addiction (Union Square Publishing) Dr. McGee has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

It can be challenging to manage chronic pain, even more so when our patients suffer from addiction. We can find ourselves walking a tightrope between the risk of relapse due to the inadequate treatment of pain, and the risk of relapse due to the use of opioid analgesics.

Using Caution While Prescribing Opioids for Pain

May 1, 2018

Amy Bohnert, PhD

Amy Bohnert, PhD Associate professor of psychiatry at the University of Michigan, Investigator at The Center for Clinical Management Research, Department of Veterans Affairs, Ann Arbor, MI Dr. Bohnert has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dosages matter. The risk of death from an overdose with patients prescribed at least 100 mg daily morphine equivalent is about 7 times higher than a patient prescribed less than 20 mg of morphine a day.

Assessing and Treating Psychogenic Pain

May 1, 2018

Howard Schubiner, MD

Howard Schubiner, MD Director of the Mind Body Medicine Program at Providence Hospital, Southfield, MI. Coauthor of the book Unlearn Your Pain: A 28-Day Process to Reprogram Your Brain. Dr. Schubiner has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

All pain is real. It’s just a question of whether that pain is being triggered by a physical injury or by something else. Studies show that emotional injury activates the same areas of the brain as does physical injury.

Prevalence of Fetal Alcohol Spectrum Disorder

May 1, 2018

Christian J. Teter, PharmD, BCPP

Christian J. Teter, PharmD, BCPP Dr. Teter has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

New evidence suggests that the prevalence of fetal alcohol spectrum disorder is higher than previously documented. In this study, prevalence estimates were derived from 13,146 first-grade children in four U.S. communities between 2010 and 2016.